CH619932A5 - - Google Patents

Download PDF

Info

Publication number
CH619932A5
CH619932A5 CH1660475A CH1660475A CH619932A5 CH 619932 A5 CH619932 A5 CH 619932A5 CH 1660475 A CH1660475 A CH 1660475A CH 1660475 A CH1660475 A CH 1660475A CH 619932 A5 CH619932 A5 CH 619932A5
Authority
CH
Switzerland
Prior art keywords
formula
compound
pyrrolidinyl
radical
preparation
Prior art date
Application number
CH1660475A
Other languages
English (en)
French (fr)
Inventor
William John Welstead Jr
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of CH619932A5 publication Critical patent/CH619932A5/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
CH1660475A 1974-12-26 1975-12-22 CH619932A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/536,708 US4002766A (en) 1974-12-26 1974-12-26 Antiarrhythmia methods

Publications (1)

Publication Number Publication Date
CH619932A5 true CH619932A5 (xx) 1980-10-31

Family

ID=24139598

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1660475A CH619932A5 (xx) 1974-12-26 1975-12-22

Country Status (18)

Country Link
US (1) US4002766A (xx)
JP (1) JPS5191255A (xx)
AU (1) AU498763B2 (xx)
BE (1) BE836974A (xx)
CA (1) CA1055396A (xx)
CH (1) CH619932A5 (xx)
DE (1) DE2558501A1 (xx)
DK (1) DK137751B (xx)
ES (1) ES443846A1 (xx)
FI (1) FI753607A (xx)
FR (1) FR2295745A1 (xx)
GB (1) GB1535770A (xx)
IE (1) IE43901B1 (xx)
NL (1) NL185620C (xx)
NO (1) NO754377L (xx)
PH (1) PH13483A (xx)
SE (1) SE428126B (xx)
ZA (1) ZA757974B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133881A (en) * 1977-04-27 1979-01-09 A. H. Robins Company, Incorporated Azetidinyl acetonitrile and acetamide antiarrhythmia compositions and methods
US4242261A (en) * 1979-07-19 1980-12-30 A. H. Robins Company, Inc. Production of methylene-cycloamines
US4260606A (en) * 1979-07-19 1981-04-07 A. H. Robins Company, Inc. 3-Methyleneazetidine derivatives
US4812452A (en) * 1984-10-19 1989-03-14 A. H. Robins Company, Incorporated 1-((aminoalkyl and aminoalkylamino) carbonyl and thiocarbonyl)-α,α-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles
US4810703A (en) * 1984-10-19 1989-03-07 A. H. Robins Company, Incorporated 1-((aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl)-alpha, alpha-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles
US4594343A (en) * 1984-10-19 1986-06-10 Shanklin Jr James R 1-[(aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl]-α,α-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles
US4812451A (en) * 1984-10-19 1989-03-14 A. H. Robins Company, Incorporated 1-(aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl)-α,.alpha.
IL76583A (en) * 1984-10-19 1988-08-31 Robins Co Inc A H 1-(aminoalkyl)-alpha'alpha-diaryl pyrrolidinyl,piperidino and homopiperidino acetamides and acetonitriles and pharmaceutical compositions containing them
GB8825505D0 (en) * 1988-11-01 1988-12-07 Pfizer Ltd Therapeutic agents
US5932594A (en) * 1988-11-01 1999-08-03 Pfizer, Inc. Muscarinic receptor antagonists
US5233053A (en) * 1989-03-17 1993-08-03 Pfizer Inc. Pyrrolidine derivatives
GB8906166D0 (en) * 1989-03-17 1989-05-04 Pfizer Ltd Therapeutic agents
US6693202B1 (en) * 1999-02-16 2004-02-17 Theravance, Inc. Muscarinic receptor antagonists
TW200800953A (en) * 2002-10-30 2008-01-01 Theravance Inc Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine
JP4767842B2 (ja) * 2003-04-01 2011-09-07 セラヴァンス， インコーポレーテッド β２アドレナリン作用性レセプターアゴニスト活性およびムスカリン性レセプターアンタゴニスト活性を有するジアリールメチル化合物および関連化合物
TW200510298A (en) * 2003-06-13 2005-03-16 Theravance Inc Substituted pyrrolidine and related compounds
WO2005007645A1 (en) * 2003-07-11 2005-01-27 Theravance, Inc. Substituted 4-amino-1-benzylpiperidine compounds
EP1723142A1 (en) * 2004-03-11 2006-11-22 Theravance, Inc. Diphenylmethyl compounds useful as muscarinic receptor antagonists
US7071224B2 (en) * 2004-03-11 2006-07-04 Theravance, Inc. Diphenylmethyl compounds useful as muscarinic receptor antagonists
TW200540154A (en) * 2004-06-10 2005-12-16 Theravance Inc Crystalline form of a substituted pyrrolidine compound
WO2007076158A2 (en) * 2005-12-27 2007-07-05 Teva Pharmaceutical Industries Ltd. Processes for preparing darifenacin hydrobromide
BRPI0807615A8 (pt) * 2007-02-23 2017-12-05 Theravance Inc Compostos de difenilmetil amônico quaternário úteis como antagonistas de receptor muscarínico
EP2146957B1 (en) * 2007-04-24 2013-06-12 Theravance, Inc. Quaternary ammonium compounds useful as muscarinic receptor antagonists
WO2012166909A1 (en) * 2011-06-03 2012-12-06 Galleon Pharmaceuticals, Inc. Compositions and methods for treating breathing control disorders or diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3192210A (en) * 1961-12-04 1965-06-29 Robins Co Inc A H 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-pyrrolidinones and 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-thionpyrrolidinones
NL6606516A (xx) * 1965-05-17 1966-11-18
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives

Also Published As

Publication number Publication date
DK137751B (da) 1978-05-01
IE43901B1 (en) 1981-07-01
ZA757974B (en) 1976-12-29
PH13483A (en) 1980-05-21
NL7515071A (nl) 1976-06-29
DE2558501C2 (xx) 1987-07-16
NL185620B (nl) 1990-01-02
ES443846A1 (es) 1977-07-16
FI753607A (xx) 1976-06-27
AU8754975A (en) 1977-06-23
NL185620C (nl) 1990-06-01
JPS5191255A (en) 1976-08-10
NO754377L (xx) 1976-06-29
IE43901L (en) 1976-06-26
DE2558501A1 (de) 1976-07-08
BE836974A (fr) 1976-04-16
DK589175A (xx) 1976-06-27
US4002766A (en) 1977-01-11
GB1535770A (en) 1978-12-13
SE428126B (sv) 1983-06-06
FR2295745B1 (xx) 1980-06-27
SE7514375L (sv) 1976-06-28
AU498763B2 (en) 1979-03-22
DK137751C (xx) 1978-10-09
JPS612658B2 (xx) 1986-01-27
CA1055396A (en) 1979-05-29
FR2295745A1 (fr) 1976-07-23

Similar Documents

Publication Publication Date Title
CH619932A5 (xx)
JP2951402B2 (ja) 抗アテローム硬化性アリール化合物
CH643546A5 (fr) Procede pour la preparation de derives d'hydantoine.
EP0041410B1 (fr) Nouveaux éthers tricycliques, leurs procédés de préparation et leur utilisation comme médicament
FR2461703A1 (fr) Procede pour preparer des composes de type methylenecycloamines
EP0133176B1 (fr) Composition pharmaceutique ou vétérinaire destinée à combattre des troubles ischémiques cardiaques
CH647233A5 (fr) Composes de methylene-3-azetidine utiles comme medicaments et compositions therapeutiques les contenant.
EP0376850A1 (fr) Dérivés du benzène, leur préparation et compositions pharmaceutiques les contenant
BE884387A (fr) Composition a base d'acides aryloxyalkylaminobenzoiques, leurs sels et leurs esters
EP1001944B1 (fr) Derives de pyrazine, leur preparation et les medicaments les contenant
CH643243A5 (fr) Cis- et trans-3-aryloxy-4-hydroxypyrrolidines et leurs derives, utiles notamment en medecine veterinaire comme antidepresseurs.
EP0079411B1 (fr) Dérivés d'indoloquinolizine, leur procédé de préparation et leur application en thérapeutique
EP0037344A1 (fr) Amino-alcoxy pyrazoles, procédé pour leur préparation, et médicaments les contenant
EP0070753A1 (fr) (Aza-1 bicyclo-(2,2,2) octyl-3) -10 10H phénothiazine-sulfonamide-2 et dérivés
FR2615511A1 (fr) Derives de benzazepines a action therapeutique
FR2500454A1 (fr) Nouveaux derives de l'ergoline, leur preparation et leur application comme medicaments
EP0103500B1 (fr) Dérivés de phénéthyl-1alpha-phényl-pipéridine-3-propanenitrile, leur préparation et leur application en thérapeutique
CH645356A5 (fr) 4-aminopyrazolidines.
LU87945A1 (fr) Derive de la dichloroaniline
FR2505824A1 (fr) Derives d'isoprenylamine et leur application a des compositions pharmaceutiques
BE646581A (xx)
LU84278A1 (fr) Phenethylpiperidines antiarythmiques
BE897146A (fr) Derives d'acide apovincaminique, procede pour leur preparation et compositions pharmaceutiques contenant ces derives
EP0026168B1 (fr) Nouveaux dérivés de décahydroquinoléinol, leur procédé de préparation ainsi que leurs applications en thérapeutique
FR2690917A1 (fr) Aminoesters, leur procédé de préparation et leur application en thérapeutique.

Legal Events

Date Code Title Description
PL Patent ceased